FIELD: medicine. SUBSTANCE: method deals with conducting a plasmapheresis by removal of 1-1.5 volume of circulating plasma per a treatment course which consists of 2-4 seances of plasmapheresis periodically in 4-8 days. Plasmapheresis provides antithrombic state of a hemostasis, improves peripheral hemocirculation and work of a heart. EFFECT: higher efficiency to achieve improved safety of a procedure in comparison with other well-known types of conservative therapy. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATION OF TREATMENT EFFECTIVENESS IN CARDIAC PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA | 2015 |
|
RU2587752C1 |
| METHOD FOR PREDICTION OF IMPAIRED PATENCY OF VEINS OF UPPER EXTREMITIES IN PATIENTS WITH IMPLANTED PACEMAKERS | 2024 |
|
RU2817995C1 |
| METHOD OF TREATING SUBACUTE VENOUS THROMBOSIS OF VARIOUS LOCALISATIONS | 2015 |
|
RU2595238C1 |
| METHOD FOR THROMBOEMBOLIC COMPLICATIONS PREDICTION | 2016 |
|
RU2621298C1 |
| METHOD OF MEDICINAL THERAPY OF DISSEMINATED MALIGNANT NEOPLASMS | 2007 |
|
RU2340355C1 |
| THERAPY OF HYPERHOMOCYSTEINEMIA | 2007 |
|
RU2360706C2 |
| METHOD FOR PREDICTION OF THROMBUS FLOTATION IN INFERIOR VENA CAVA WITH USING MOLECULAR GENETIC MONITORING ADDITIONALLY | 2012 |
|
RU2517215C2 |
| ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 |
|
RU2571555C1 |
| METHOD FOR MODELING PULMONARY ARTERY THROMBOSIS IN CONDITIONS OF VENOUS THROMBOSIS | 2021 |
|
RU2770355C1 |
| METHOD FOR PREDICTING PULMONARY ARTERIAL EMBOLIZATION IN ONCOLOGY PATIENTS WITH LOWER EXTREMITY PHLEBOTHROMBOSIS | 2016 |
|
RU2664448C2 |
